APA aipamena

Inwards, D. J., Fishkin, P. A. S., Hillman, D. W., Brown, D. W., Ansell, S. M., Kurtin, P. J., . . . Witzig, T. E. (2008). Long-term Results of the Treatment of Patients With Mantle Cell Lymphoma With Cladribine (2-CDA) Alone (95-80-53) or 2-CDA and Rituximab (N0189) in the North Central Cancer Treatment Group.

Chicago Style aipamena

Inwards, David J., et al. Long-term Results of the Treatment of Patients With Mantle Cell Lymphoma With Cladribine (2-CDA) Alone (95-80-53) or 2-CDA and Rituximab (N0189) in the North Central Cancer Treatment Group. 2008.

MLA aipamena

Inwards, David J., et al. Long-term Results of the Treatment of Patients With Mantle Cell Lymphoma With Cladribine (2-CDA) Alone (95-80-53) or 2-CDA and Rituximab (N0189) in the North Central Cancer Treatment Group. 2008.